Reversible complete left bundle branch block and a wide QRS complex following administration of sodium-glucose cotransporter-2 inhibitor and volume reduction in a patient with systolic heart failure: a case report.
使用鈉-葡萄糖共轉運蛋白-2抑制劑及減少血容量後,出現可逆性完全左束支傳導阻滯及寬 QRS 複合波的心臟衰竭患者:個案報告。
Eur Heart J Case Rep 2024-09-30
Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.
心臟衰竭降低射出分數患者合併使用鈉葡萄糖共同運輸蛋白-2抑制劑和血管收縮素受體-內皮酶抑制劑治療引發嚴重低血壓:一個病例報告。
J Pharm Pract 2024-02-16
Left Ventricular Systolic Function After 3 Months of SGLT2 Inhibitor Therapy in Heart Failure Patients with Reduced Ejection Fraction.
心力衰竭患者使用 SGLT2 抑制劑治療後3個月的左心室收縮功能。
J Cardiovasc Transl Res 2023-11-20
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
SGLT-2 抑制劑對收縮功能減弱心衰左心臟重塑的影響:系統性回顧與荟萃分析。
Eur J Heart Fail 2024-03-27
Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure.
Empagliflozin和Dapagliflozin治療有利地改變心臟衰竭患者的QRS-T角度和心臟重極化參數。
J Innov Card Rhythm Manag 2024-05-08
A Case of BRASH (Bradycardia, Renal Dysfunction, Atrioventricular Node Blockade, Shock, and Hyperkalemia) Syndrome Following Initiation of a Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor and a Loop Diuretic.
一例因啟用鈉-葡萄糖共轉運蛋白-2 (SGLT-2) 抑制劑和環利尿劑而引發的BRASH (心動過緩、腎功能不全、房室結阻滯、休克及高鉀血症) 綜合症。
Cureus 2024-07-23
Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis.
SGLT2 抑制對心衰竭中逆向心臟重塑標記的影響:系統性回顧與統合分析。
ESC Heart Fail 2024-07-26
The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus.
SGLT-2 抑制劑對於心臟射出分數降低及糖尿病患者的超聲心動圖指標和抗氧化特性的影響。
Eur Rev Med Pharmacol Sci 2024-09-04